''This week's opening of Walmart's second comprehensive primary care center in Georgia may signal a looming competitive threat to health systems and primary care providers, potentially creating new pressure to reduce prices. The giant retailer launched ...'

''A total-body PET/CT scanner paired with an advanced sub-second molecular image technique can enable real-time blood-flow tracking and motion-frozen imaging of cardiovascular and respiratory functions, according to newly published research. The ...'

''A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of global medical x-ray tube market. The report analyzes ...'

''The discoveries and inventions made until today are based on two aspects. The first one is made on a purpose, most often to fulfil a need. The second one is rather a quite interesting one, that is, accidental discoveries and ...'

''For patients who fail to respond to current first-line and second-line treatments for colorectal cancer liver metastases (also known as salvage patients), radioembolization with Y-90 microspheres could extend survival according to new research published ...'

''Researchers using a newly approved advanced computed tomography (CT) system were able to significantly reduce radiation exposure in patients undergoing coronary CT angiography (CCTA), according to a new study published online in the journal Radiology. ...'

''One of the most urgently sought-after goals in modern science is the ability to observe the detailed dynamics of chemical reactions as they happen – that is, on the spatial scale of molecules, atoms, and electrons, and on the time scale of picoseconds or ...'

''At the Micro and Nano Laboratory in Gaustadbekkdalen in Oslo, scientists have created one of the most advanced radiation sensors in the world: an X-ray detector that can reveal the composition of materials in a fraction of a second. The sensor has ...'

''International Isotopes Inc. (OTC Bulletin Board: INIS) announces financial results for the second quarter and six-months ended June 30, 2011. Revenue for the three-month period ended June 30, 2011, was $2,614,744, as compared to $1,485,293 for the ...'

''Neoprobe Corporation (NYSE Amex: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, today announced that full results from the NEO3-05 study, demonstrating Lymphoseek® (99mTc-tilmanocept) met all primary and secondary ...'